Finding Natural Ingredients in Angelica Root That Fight Inflammation

Jim Crocker
13th February, 2025

Finding Natural Ingredients in Angelica Root That Fight Inflammation

Angelica sinensis

Photo adapted from: Wikimedia Commons / CC BY SA (Source)

Key Findings

  • A team at the Chinese Academy of Sciences identified new anti-inflammatory compounds from Angelica sinensis, a traditional East Asian medicinal plant
  • One compound significantly reduced inflammation in cell studies by lowering key inflammatory signals
  • These discoveries support traditional uses and could lead to the development of new anti-inflammatory medications
Angelica sinensis, commonly known as Dang Gui, has been a cornerstone of traditional medicine in East Asia for centuries, primarily used to enhance blood health and alleviate various ailments such as menstrual irregularities and pain[2]. Modern scientific interest has increasingly focused on its potential therapeutic properties, including anti-inflammatory and anti-tumor activities[3][4]. A recent study conducted by researchers at the Chinese Academy of Sciences has further expanded our understanding of this medicinal plant by identifying new compounds with significant anti-inflammatory effects[1]. In their study, the researchers employed a bioactivity-guided approach combined with HSQC (Heteronuclear Single Quantum Coherence) characteristic signals to isolate and identify nine pairs of phthalic dimers, named angesilides A-I (1-9), from the rhizomes of Angelica sinensis. These compounds feature complex polycyclic structures with bridged, fused, and spiro ring systems, showcasing the chemical diversity inherent in the plant. To determine the precise structures and configurations of these molecules, the team utilized comprehensive spectroscopic methods, X-ray diffraction analysis, and chiral separation techniques. Understanding the biosynthetic pathways of these compounds is crucial for potential large-scale production and further pharmacological studies. The researchers proposed plausible biosynthetic routes for angesilides A-I, providing a foundation for future investigations into how these molecules are formed within the plant. This insight not only deepens our knowledge of Angelica sinensis's chemistry but also opens avenues for synthesizing these compounds in the laboratory. The anti-inflammatory properties of the isolated compounds were a primary focus of the study. Using lipopolysaccharide (LPS)-stimulated mouse leukemia cells of monocyte macrophages (RAW 264.7), the researchers evaluated the efficacy of each compound in reducing inflammation. Among the nine isolates, compound 9 stood out with an impressive inhibitory concentration (IC50) value of 425 nM, indicating a potent ability to suppress inflammatory activity. This compound significantly decreased the transcription levels of pro-inflammatory cytokines IL-1β and IL-6, which play critical roles in the body's inflammatory response. Further analysis revealed that the two enantiomers of compound 9 exhibited different levels of activity. The (+)-9 enantiomer demonstrated superior nitric oxide (NO) inhibitory activity compared to the (-)-9 enantiomer. Nitric oxide is a key mediator in inflammation, and its excessive production is associated with various inflammatory diseases. The enhanced activity of (+)-9 was confirmed through molecular docking analysis, which showed a stronger interaction with target proteins involved in the inflammatory pathway. This finding highlights the importance of stereochemistry in the biological activity of natural compounds. The discovery of these new anti-inflammatory agents from Angelica sinensis not only supports its traditional use in managing inflammation-related conditions but also presents promising candidates for the development of new anti-inflammatory drugs. Previous studies have demonstrated the plant's broad pharmacological effects, including anti-tumor activities[4] and benefits in treating ischemic stroke[5]. The identification of angesilides A-I adds to the arsenal of bioactive compounds derived from Angelica sinensis, potentially leading to more effective and targeted therapies. Incorporating earlier findings, the current study builds on the extensive review of Angelica sinensis's phytochemistry and pharmacology[2]. The comprehensive analysis of bioactive components, such as polysaccharides and ferulic acid, has laid the groundwork for isolating and characterizing new compounds like angesilides[2]. Additionally, the anti-inflammatory effects observed align with previous research highlighting the plant's ability to modulate inflammatory pathways[3]. This continuity underscores the plant's multifaceted therapeutic potential and its relevance in contemporary medical research. The methodologies employed in this study, including advanced spectroscopic techniques and bioactivity-guided isolation, demonstrate the sophistication required to unlock the full potential of traditional medicinal plants. By systematically identifying and testing each compound, the researchers ensured a thorough evaluation of Angelica sinensis's bioactive constituents. This approach not only validates the plant's traditional uses but also bridges the gap between ethnopharmacology and modern drug discovery. The implications of this research are significant. The discovery of potent anti-inflammatory compounds from Angelica sinensis could lead to the development of new treatments for a range of inflammatory diseases, offering alternatives to existing medications with potentially fewer side effects. Moreover, understanding the specific activities of different enantiomers provides valuable insights into the design of more effective drugs with targeted actions. Future research should focus on detailed mechanistic studies to elucidate how these angesilides interact with specific molecular targets within the inflammatory pathways. Additionally, exploring the therapeutic potential of these compounds in vivo will be essential to assess their efficacy and safety in more complex biological systems. Given the promising results, there is also potential for these compounds to be integrated into functional foods or nutraceuticals, further leveraging the health benefits of Angelica sinensis. Overall, this study by the Chinese Academy of Sciences marks a significant advancement in the scientific exploration of Angelica sinensis. By uncovering new anti-inflammatory compounds and elucidating their mechanisms of action, the research not only honors the plant's traditional legacy but also paves the way for innovative medical applications. As scientists continue to explore the rich chemical landscape of traditional herbs, discoveries like these highlight the enduring value of integrating ancient knowledge with modern science.

HerbsMedicineBiochem

References

Main Study

1) Bioassay and NMR-HSQC-Guided Isolation and Identification of Phthalide Dimers with Anti-Inflammatory Activity from the Rhizomes of Angelica sinensis.

Published 12th February, 2025

https://doi.org/10.1021/acs.jafc.4c11704

Related Studies

2) Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis.

https://doi.org/10.1016/j.jep.2016.05.023

3) Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-kappaB trans-activation activity and LPS-induced inflammation.

https://doi.org/10.1016/j.jep.2010.03.022

4) Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis.

Journal: World journal of gastroenterology, Issue: Vol 9, Issue 9, Sep 2003

5) Overview of therapeutic potentiality of Angelica sinensis for ischemic stroke.

https://doi.org/10.1016/j.phymed.2021.153652


Related Articles

An unhandled error has occurred. Reload 🗙